4 unchanged sentences
“Disclosure controls and procedures” include, without limitation, controls and procedures designed to ensure that information that we are required to disclose in the reports we file with the Commission is accumulated and communicated to our principal executive officer and principal financial officer as appropriate to allow timely decisions regarding required disclosure.
−Removed: Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of December 31, 2020 as a result of the material weakness in our internal control over financial reporting discussed below.
+Added: Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of December 31, 2021.
Management Report on Internal Control over Financial Reporting
9 unchanged sentences
In conducting its assessment, our management used the criteria issued by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework in 2013 .
−Removed: Based on this assessment, our management concluded that, as of December 31, 2020, our internal control over financial reporting was not effective based on those criteria because of a material weakness described below.
−Removed: The material weakness in internal control over financial reporting resulted from a deficiency in our disclosure controls and procedures which could have resulted in the Company not disclosing a material potential loss requiring a qualitative disclosure and recording a liability in consolidated financial statements under ASC 450 - Contingencies.
−Removed: The material weakness was previously identified as of December 31, 2019.
−Removed: Specifically, the Company failed to disclose in its Quarterly Report on Form 10-Q for the period ended September 30, 2020 that the Company received a letter in September 2020 from a customer requesting a full refund of approximately $1.6 million of NIAGEN® it purchased, alleging breaches of the supply agreement between the parties, and failed to record a liability in its financial statements for such quarter.
−Removed: The Company is still in the process of analyzing and addressing the material weakness.
−Removed: The material weakness will not be considered remediated until the applicable remedial control operates for a sufficient period of time and management has concluded, through testing, that this control is operating effectively.
−Removed: We expect that the remediation of this material weakness will be completed prior to the end of year 2021.
−Removed: Our principal executive officer and principal financial officer believe that, notwithstanding the material weakness discussed above, the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2020 present fairly, in all material respects, our financial position, results of operations and cash flows for the periods presented.
−Removed: In connection with the filing of our Quarterly Report on Form 10-Q for the period ended September 30, 2020, our chief executive officer and our chief financial officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of September 30, 2020, previously concluded that our disclosure controls and procedures were effective, and that the material weakness previously identified and described above had been remediated.
−Removed: Subsequent to that evaluation, management reevaluated the effectiveness of our disclosure controls and procedures as of September 30, 2020 and concluded that our disclosure controls and procedures over financial reporting were not effective as the previously identified material weakness discussed above was not remediated as of September 30, 2020.
−Removed: Our principal executive officer and principal financial officer believe that, notwithstanding the material weakness discussed above, the consolidated financial statements in our Quarterly Report on Form 10-Q for the period ended September 30, 2020 present fairly, in all material respects, our financial position, results of operations and cash flows for the periods presented.
+Added: Based on this assessment, our management concluded that, as of December 31, 2021, our internal control over financial reporting was effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
+Added: Previously Identified Material Weaknesses in Internal Control Over Financial Reporting
+Added: A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.
+Added: We previously identified and disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020 a material weakness in our internal control over financial reporting which resulted from a deficiency in our disclosure controls and procedures which could have resulted in the Company not disclosing a material potential loss requiring a qualitative disclosure and recording a liability in consolidated financial statements under ASC 450 - Contingencies.
+Added: Remediation Efforts of Previously Disclosed Material Weaknesses
+Added: Subsequent to the evaluation made in connection with filing our Annual Report on Form 10-K for the year ended December 31, 2020, management, with the oversight of the Audit Committee of the Board of Directors, continued the process of remediating the material weakness.
+Added: During the year ended December 31, 2021, we completed our plans to remediate the material weakness by implementing and enhancing controls in the financial reporting close process surrounding the identification and inclusion of all new litigation, asserted and unasserted claims, and assessments over a material threshold in a log provided to the Company’s disclosure committee for evaluation on a quarterly basis.
+Added: Management completed testing and evaluation, and based on the result, determined that as of December 31, 2021, the control operated effectively for a sufficient period of time.
+Added: Therefore management concluded that the material weakness previously identified has been remediated.
Changes in Internal Control over Financial Reporting
10 unchanged sentences
Other Information
−Removed: On March 9, 2021, Mark Friedman, the Company’s Chief Legal Officer, notified the Company that he intends to retire, effective March 12, 2021 (the “Retirement Date”).
−Removed: Friedman entered into a consultant agreement (the “Consulting Agreement”) whereby Mr.
−Removed: Friedman will provide certain advisory services to the Company for a period of 90 days following the Retirement Date in exchange for a cash payment of $12,000 per month.
−Removed: The services provided pursuant to the Consulting Agreement will constitute continuous service with the Company.
−Removed: The Consulting Agreement may be renewed for additional one-month terms upon written agreement by both parties, and may be terminated by either party upon 30 days’ written notice.
−Removed: In connection with Mr.
−Removed: Friedman’s retirement, the Company expects that Lisa Hatton Harrington, the Company’s General Counsel, will be appointed as an executive officer of the Company and will materially assume the duties and responsibilities of Mr.
+Added: Effective March 10, 2022, the Board of Directors (the “Board”) of ChromaDex Corporation (the “Company”) adopted and approved amended and restated bylaws of the Company to, among other things, provide that the Board may in its sole discretion determine to hold meeting of stockholders solely by remote communications, limit the power and authority of an executive committee appointed by the Board, provide for electronic transmission of stockholder consent to the extent permitted by applicable law, and to consolidate a previous amendment.
+Added: The foregoing summary of the amended and restated bylaws is qualified in its entirety by reference to the complete text of the amended and restated bylaws, a copy of which is filed as Exhibit 3.3 with this Annual Report on Form 10-K and is incorporated herein by reference.
+Added: Disclosures regarding Foreign Jurisdictions that Prevent Inspections
+Added: Not Applicable.
Directors, Executive Officers and Corporate Governance
−Removed: Information required by this item will be contained in the Proxy Statement and is incorporated herein by reference.
−Removed: We have adopted a written Code of Business Conduct and Ethics (the “Ethics Code”) that applies to all officers, directors and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions.
−Removed: The Ethics Code is available on our website at www.chromadex.com.
−Removed: If we make any substantive amendments to the Ethics Code or grant any waiver from a provision of the Ethics Code to any executive officer or director, we will promptly disclose the nature of the amendment or waiver on our website or in a Current Report on Form 8-K.
+Added: Information required by this item will be contained in the Proxy Statement as follows:
+Added: • The information relating to our executive officers is to be included in the section entitled “Executive Officers,”
+Added: • The information relating to our directors and nominees for director is to be included in the section entitled “Election of Directors” and “Information Regarding the Board of Directors and Corporate Governance,”
+Added: • The information relating to our audit committee and audit committee financial expert is to be included in the section “Information Regarding the Board of Directors and Corporate Governance,” and
+Added: • If required, the information regarding compliance with Section 16(a) of the Exchange Act is to be included in the section entitled “Delinquent Section 16(a) Reports.”
+Added: Such information will be included in the Proxy Statement and is incorporated herein by reference.
+Added: We have adopted a written Code of Business Conduct and Ethics (Code of Conduct) that applies to all officers, directors and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions.
+Added: The Code of Conduct is available on our website at www.chromadex.com.
+Added: If we make any substantive amendments to the Code of Conduct or grant any waiver from a provision of the Code of Conduct to any executive officer or director, we will promptly disclose the nature of the amendment or waiver on our website or in a Current Report on Form 8-K.
Executive Compensation
−Removed: Information required by this item will be contained in the Proxy Statement and is incorporated herein by reference.
+Added: Information required by this item will be contained in the Proxy Statement under the caption “Executive Officers and Management Compensation” and is incorporated herein by reference.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
−Removed: Information required by this item will be contained in the Proxy Statement and is incorporated herein by reference.
+Added: Information required by this item will be contained in the Proxy Statement under the caption “Security Ownership of Certain Beneficial Owners and Management” and is incorporated herein by reference.
Certain Relationships and Related Transactions, and Director Independence
−Removed: Information required by this item will be contained in the Proxy Statement and is incorporated herein by reference.
+Added: Information required by this item will be contained in the Proxy Statement under the caption “Certain Relationships and Related Transactions” and “Information Regarding the Board of Directors and Corporate Governance” and is incorporated herein by reference.
Principal Accounting Fees and Services
−Removed: Information required by this item will be contained in the Proxy Statement and is incorporated herein by reference.
+Added: Our independent registered public accounting firm is Marcum LLP, New York, NY, Audit Firm ID:
+Added: The information required by this item is to be included in our Proxy Statement under the caption “Ratification of the Appointment of Independent Registered Public Accounting Firm” and is incorporated herein by reference.
Exhibits and Financial Statement Schedules
9 unchanged sentences
333-140056) filed with the Commission on June 24, 2008) (1)
−Removed: Asset Purchase Agreement, dated as of August 21, 2017, by and among Covance Laboratories Inc., ChromaDex, Inc., ChromaDex Analytics, Inc., and ChromaDex Corporation (incorporated by reference to, and filed as Exhibit 2.2 to the Registrant’s Quarterly Report on Form 10-Q (File No.
−Removed: 001-37752) filed with the Commission on November 9, 2017)*(2)
−Removed: Amendment to Asset Purchase Agreement, dated as of September 5, 2017, by and among Covance Laboratories Inc., ChromaDex, Inc., ChromaDex Analytics, Inc., and ChromaDex Corporation (incorporated by reference to, and filed as Exhibit 2.2 to the Registrant’s Quarterly Report on Form 10-Q (File No.
−Removed: 001-37752) filed with the Commission on November 9, 2017)
Amended and Restated Certificate of Incorporation of the Registrant (incorporated by reference to, and filed as Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K (File No.
2 unchanged sentences
000-53290) filed with the Commission on April 12, 2016)
−Removed: Bylaws of the Registrant (incorporated by reference to, and filed as Exhibit 3.2 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 333-140056) filed with the Commission on June 24, 2008)
−Removed: Amendment to Bylaws of the Registrant (incorporated by reference to, and filed as Exhibit 3.1 to the Registrant’s Current Report on Form 8-K (File No.
−Removed: 001-37752) filed with the Commission on July 19, 2016)
+Added: Amended and Restated Bylaws of the Registrant
Form of Stock Certificate representing shares of the Registrant’s Common Stock (incorporated by reference to, and filed as Exhibit 4.1 of the Registrant’s Annual Report on Form 10-K (File No.
14 unchanged sentences
Registration Rights Agreement, dated as of April 27, 2020, by and among the Registrant and the parties thereto (incorporated by reference to Exhibit 99.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on April 29, 2020)
+Added: Registration Rights Agreement, dated as of February 20, 2021, by and among the Registrant and Everfund (incorporated by reference to Exhibit 99.2 to the Registrant’s Current Report on Form 8-K filed with the SEC on February 22, 2022 )
Second Amended and Restated 2007 Equity Incentive Plan effective March 13, 2007, as amended May 20, 2010 (incorporated by reference to, and filed as Appendix B to the Registrant’s Current Definitive Proxy Statement on Schedule 14A (File No.
22 unchanged sentences
000-53290) filed with the Commission on August 13, 2015)*
−Removed: License Agreement, dated July 5, 2011 between ChromaDex, Inc.
−Removed: and Cornell University (incorporated by reference to, and filed as Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (File No.
−Removed: 000-53290) filed with the Commission on November 10, 2011)*
−Removed: Exclusive License Agreement, dated September 8, 2011 between the Regents of the University of California and ChromaDex, Inc.
−Removed: (incorporated by reference to, and filed as Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q (File No.
−Removed: 000-53290) filed with the Commission on November 10, 2011)*
First Amendment to the License Agreement, effective as of September 5, 2014 between the Regents of the University of California and ChromaDex, Inc.
37 unchanged sentences
Fordham LLC and 64-1625-1751 S.
−Removed: Fordham LLC are successors-in-interest to Lease Agreement, made as of April 14, 2016, by and between ChromaDex Analytics, Inc and Longmont Diagonal Investments LLC) (incorporated by reference to Exhibit 10.8 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 4, 2020)
+Added: Fordham LLC are successors-in-interest to Lease Agreement, made as of April 14, 2016, by and between ChromaDex Analytics, Inc and Longmont Diagonal Investments LLC) (incorporated by reference to Exhibit 10.8 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on November 4, 2020)
Form of Indemnity Agreement, between the Registrant and each of its existing directors and executive officers.
26 unchanged sentences
001-37752) filed with the Commission on October 10, 2017)+
+Added: Securities Purchase Agreement dated April 26, 2017, by and among the Company and the Purchasers (incorporated by reference from and filed as Exhibit 99.1 to the Company's Current Report on Form 8-K filed with the Commission on April 27, 2017)
Executive Employment Agreement, dated as of January 22, 2018, by and between Mark Friedman and the Registrant (incorporated by reference to and filed as Exhibit 10.72 to the Registrant’s Annual Report on Form 10-K (File No.
001-37752) filed with the Commission on March 15, 2018)+
−Removed: Executive Employment Agreement, dated as of June 1, 2018, by and between Lisa Bratkovich and the Registrant (incorporated by reference to, and filed as Exhibit 10.58 to the Registrant’s Annual Report on Form 10-K (File No.
−Removed: 001-37752) filed with the Commission on March 7, 2019)+
−Removed: Separation Agreement, dated January 10, 2020, by and among ChromaDex Corporation and Lisa Bratkovich (incorporated by reference to and filed as Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (File No.
−Removed: 001-37752) filed with the Commission on May 18, 2020)+
Supply Agreement, dated December 19, 2018, by and between ChromaDex, Inc.
and Nestec Ltd.
−Removed: (incorporated by reference to, and filed as Exhibit 10.62 to the Registrant’s Annual Report on Form 10-K (File No.
−Removed: 001-37752) filed with the Commission on March 7, 2019)*
Note Purchase Agreement, dated May 9, 2019, by and among ChromaDex Corporation and Winsave Resource Limited and Pioneer Step Holdings Limited (incorporated by reference to, and filed as Exhibit 99.1 to the Registrant’s Current Report on Form 8-K (File No.
13 unchanged sentences
001-37752) filed with the Commission on March 10, 2020)
−Removed: First Modification to Business Financing Agreement dated October 7, 2020, by and between ChromaDex Corporation and Western Alliance Bank v
+Added: First Modification to Business Financing Agreement dated October 7, 2020, by and between ChromaDex Corporation and Western Alliance Bank (incorporated by reference to Exhibit 10.43 to the Registrant’s Annual Report on Form 10-K (File No.
+Added: 001-37752) filed with the Commission on March 12, 2021)
+Added: Second Modification to Business Financing Agreement dated November 10 , 2021, by and between ChromaDex Corporation and Western Alliance Bank v
+Added: Third Modification to Business Financing Agreement dated December 11, 2021 by and among Western Alliance Bank, ChromaDex Corporation, ChromaDex, Inc.
+Added: and ChromaDex Analytics, Inc.
+Added: (incorporated by reference to Exhibit 10.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-37752) filed with the SEC on December 14, 2021)
Manufacturing and Supply Agreement, dated as of January 1, 2016, by and between ChromaDex, Inc.
Grace & Co.-Conn.
−Removed: (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 4, 2020) **
+Added: (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on November 4, 2020) **
Amendment to Manufacturing and Supply Agreement, dated as of February 27, 2017, by and between ChromaDex, Inc.
Grace & Co.-Conn.
−Removed: (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 4, 2020) **
+Added: (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on November 4, 2020) **
Second Amendment to Manufacturing and Supply Agreement, dated as of January 1, 2018, by and between ChromaDex, Inc.
Grace & Co.-Conn.
−Removed: (incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 4, 2020) **
+Added: (incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on November 4, 2020) **
Third Amendment to Manufacturing and Supply Agreement, dated as of January 1, 2019, by and between ChromaDex, Inc.
Grace & Co.-Conn.
−Removed: (incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 4, 2020) **
+Added: (incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on November 4, 2020) **
Fourth Amendment to Manufacturing and Supply Agreement, dated as of April 15, 2019, by and between ChromaDex Inc.
Grace & Co.-Conn.
−Removed: (incorporated by reference to Exhibit 10.5 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 4, 2020) **
+Added: (incorporated by reference to Exhibit 10.5 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on November 4, 2020) **
Fifth Amendment to Manufacturing and Supply Agreement, dated as of January 1, 2020, by and between ChromaDex Inc.
Grace & Co.-Conn.
−Removed: (incorporated by reference to Exhibit 10.6 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 4, 2020) **
+Added: (incorporated by reference to Exhibit 10.6 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on November 4, 2020) **
Sixth Amendment to Manufacturing and Supply Agreement, dated as of September 17, 2020, by and between ChromaDex Inc.
Grace & Co.-Conn.
−Removed: (incorporated by reference to Exhibit 10.7 to the Registrant’s Quarterly Report on Form 10-Q filed with the SEC on November 4, 2020) **
−Removed: Executive Employment Agreement, dated as of July 23, 2019, by and between Megan Jordan and the Registrant v +
+Added: (incorporated by reference to Exhibit 10.7 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on November 4, 2020) **
+Added: Seventh Amendment to Manufacturing and Supply Agreement, dated as of August 2, 2021, by and between ChromaDex Inc.
+Added: Grace & Co.-Conn.
+Added: (incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on August 3, 2021) **
+Added: Executive Employment Agreement, dated as of July 23, 2019, by and between Megan Jordan and the Registrant (incorporated by reference to Exhibit 10.52 to the Registrant’s Annual Report on Form 10-K (File No.
+Added: 001-37752) filed with the Commission on March 12, 2021) +
+Added: Securities Purchase Agreement, dated February 20, 2021, by and between the Company and Everfund (incorporated by reference to Exhibit 99.1 to the Registrant’s Current Report on Form 8-K (File No.
+Added: 001-37752) filed with the SEC on February 22, 2021)
+Added: Consultant Agreement, dated March 15, 2021, by and between Mark Friedman and the Registrant (incorporated by reference to Exhibit 10.3 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on May 6, 2021)
+Added: Consent to Business Financing Agreement, dated January 14, 2021, by and among Western Alliance Bank and ChromaDex Corporation (incorporated by reference to Exhibit 10.4 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on May 6, 2021)
+Added: Fifth Amendment to Lease, dated May 21, 2021, by and between 10900 WILSHIRE L.L.C and ChromaDex, Inc.
+Added: (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on August 3, 2021)
+Added: License Agreement, dated July 5, 2011 between ChromaDex, Inc.
+Added: and Cornell University (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on August 3, 2021) **
+Added: Exclusive License Agreement, dated September 8, 2011, by and between ChromaDex, Inc.
+Added: and The Regents of the University of California (incorporated by reference to Exhibit 10.1 to the Registrant’s Quarterly Report on Form 10-Q (File No.
+Added: 001-37752) filed with the SEC on November 3, 2021)**
+Added: Lease, dated Novem ber 24, 2021 , by and between Flight Phase I Owner, LLC and ChromaDex, Inc.
+Added: Executive Employment Agreement, dated November 13, 2021, by and between Lisa H.
+Added: Harrington and the Registrant (incorporated by reference to Exhibit 10.2 to the Registrant’s Quarterly Report on Form 10-Q f iled with the SEC on May 6, 2021)
Subsidiaries of ChromaDex Corporation v
Consent of Marcum, LLP, Independent Registered Public Accounting Firm v
−Removed: Certification of the Chief Executive Officer pursuant to §240.13a-14 or §240.15d-14 of the Securities Exchange Act of 1934, as amended
−Removed: Certification of the Chief Financial Officer pursuant to §240.13a-14 or §240.15d-14 of the Securities Exchange Act of 1934, as amended
+Added: Certification of the Chief Executive Officer pursuant to §240.13a-14 or §240.15d-14 of the Securities Exchange Act of 1934, as amended v
+Added: Certification of the Chief Financial Officer pursuant to §240.13a-14 or §240.15d-14 of the Securities Exchange Act of 1934, as amended v
Certification pursuant to 18 U.S.C.
Section 1350 (as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002) v
−Removed: XBRL Instance Document
−Removed: XBRL Taxonomy Extension Schema Document
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: XBRL Taxonomy Extension Definition Linkbase Document
−Removed: XBRL Taxonomy Extension Label Linkbase Document
−Removed: XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: Filed herewith.
+Added: 101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
+Added: 101.SCH Inline XBRL Taxonomy Extension Schema Document
+Added: 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document
+Added: 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document
+Added: 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document
+Added: 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document
+Added: 104 Cover Page Interactive Data File - formatted in Inline XBRL and included in Exhibit 101
+Added: v Filed herewith.
(1) Plan and related Forms were assumed by ChromaDex Corporation pursuant to Agreement and Plan of Merger, dated as of May 21, 2008, among ChromaDex Corporation (formerly Cody Resources, Inc.), CDI Acquisition, Inc.
6 unchanged sentences
The confidential portions of this Exhibit have been omitted and are marked by an asterisk.
−Removed: Certain portions of this exhibit are omitted because they are not material and would likely cause competitive harm to the registrant if disclosed.
+Added: ** Certain portions of this exhibit are omitted because they are both not material and are the type that the Registrant treats as private or confidential.
Form 10-K Summary
−Removed: Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on the 12th day of March 2021.
+Added: Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CHROMADEX CORPORATION
1 unchanged sentence
Chief Executive Officer
−Removed: KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Robert Fried and Kevin Farr, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.
+Added: KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Robert Fried and Kevin Farr, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them, or their or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.
−Removed: /s/ ROBERT FRIED
−Removed: Chief Executive Officer and Director
−Removed: March 12, 2021
−Removed: (Principal Executive Officer)
−Removed: /s/ KEVIN FARR
−Removed: Chief Financial Officer
−Removed: March 12, 2021
−Removed: (Principal Financial and Accounting Officer)
−Removed: Executive Chairman of the Board and Director
−Removed: March 12, 2021
−Removed: /s/ STEPHEN BLOCK
−Removed: March 12, 2021
+Added: Signature Title Date
+Added: /s/ ROBERT FRIED Chief Executive Officer and Director March 14, 2022
+Added: Robert Fried (Principal Executive Officer)
+Added: /s/ KEVIN FARR Chief Financial Officer March 14, 2022
+Added: Kevin Farr (Principal Financial and Accounting Officer)
+Added: Executive Chairman of the Board and Director March 14, 2022
+Added: /s/ STEPHEN BLOCK Director March 14, 2022
Stephen Block
−Removed: /s/ JEFF BAXTER
−Removed: March 12, 2021
−Removed: /s/ KURT GUSTAFSON
−Removed: March 12, 2021
+Added: /s/ JEFF BAXTER Director March 14, 2022
+Added: /s/ KURT GUSTAFSON Director March 14, 2022
Kurt Gustafson
−Removed: /s/ STEVEN RUBIN
−Removed: March 12, 2021
−Removed: March 12, 2021
−Removed: March 12, 2021
+Added: /s/ STEVEN RUBIN Director March 14, 2022
+Added: /s/ WENDY YU Director March 14, 2022
+Added: /s/ CAROLINE LEVY Director March 14, 2022
+Added: Caroline Levy
+Added: /s/ GARY NG Director March 14, 2022
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.